Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15), b) 30 g tubes ...

FDA Drug Recall #D-0636-2017 — Class III — March 20, 2017

Recall Summary

Recall Number D-0636-2017
Classification Class III — Low risk
Date Initiated March 20, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm G & W Laboratories, Inc.
Location South Plainfield, NJ
Product Type Drugs
Quantity 230,700 tubes

Product Description

Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15), b) 30 g tubes (NDC 0713-0638-31), and c) 90 g tubes (NDC 0713-0638-18), Rx only, Manufactured by: G&W Laboratories, Inc., South Plainfeld, NJ 07080.

Reason for Recall

Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.

Distribution Pattern

Nationwide in the USA and Puerto Rico

Lot / Code Information

Lot #: a) 63800090, Exp 04/17; 63800095, Exp 11/17; 1000573, Exp 02/18; 1002560, Exp 06/18; b) 63800090, Exp 04/17; 63800092, Exp 07/17; 63800093, Exp 08/17; 63800095, Exp 11/17; 1000574, Exp 02/18; 1001772, Exp 05/18; c) 63800089, Exp 03/17; 63800091, Exp 07/17; 63800094, Exp 08/17; 1000842, Exp 01/18; 1000966, Exp 03/18; 1001771, Exp 05/18; 1002562, Exp 06/18.

Other Recalls from G & W Laboratories, Inc.

Recall # Classification Product Date
D-0250-2018 Class III Ciclopirox Olamine Cream USP, 0.77%, packaged i... Jan 19, 2018
D-0945-2017 Class III G & W Clobetasol Propionate Ointment 0.05%, pac... Jun 2, 2017
D-0519-2017 Class III Clindamycin Phosphate Topical Solution USP, 1%,... Feb 28, 2017
D-0501-2017 Class II Indocin (Indomethacin) suppositories, USP, 50 m... Feb 7, 2017

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.